Cannabinoid CB1 receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.

Risultato della ricerca: Article

24 Citazioni (Scopus)

Abstract

The purpose of the present study was to examine whether cannabinoid receptor agonists influence spontaneous contractile activity oflongitudinal muscle in mouse ileum in vitro. Isolated segments of mouse ileum displayed spontaneous contractions with an amplitude andfrequency of about 300 mg and 30 cpm, respectively. The endocannabinoid anandamide (1–100 μM), the selective cannabinoid CB1 receptoragonist, ACEA (0.1 μM–10 μM), but not the selective cannabinoid CB2 receptor agonist, JWH 133 (0.1 μM–10 μM), reduced in a concentrationdependentmanner the spontaneous mechanical activity. The inhibitory effect consisted in a decrease of the mean amplitude of longitudinalspontaneous contractions, without changes in the resting tone. The inhibitory effect induced by cannabinoids was significantly antagonized by theselective cannabinoid CB1 receptor antagonist, SR141716A (0.1 μM), but not by the selective cannabinoid CB2 receptor antagonist, AM630(0.1 μM). None of the cannabinoid antagonists, at the concentration used, did affect the spontaneous mechanical activity. The ACEA-inducedreduction of spontaneous contractions was almost abolished by tetrodotoxin, atropine or apamin and it was unaffected by hexamethonium orNω-nitro-L-arginine methyl ester (L-NAME), inhibitor of nitric oxide synthase. The myogenic contractions evoked by carbachol were notaffected by ACEA. In conclusion, the present results suggest that activation of neural cannabinoid CB1 receptors may play a role in the controlof spontaneous mechanical activity through inhibition of acetylcholine release from cholinergic nerve. Activation of small conductance Ca2+-dependent K+ channels is involved in this action.
Lingua originaleEnglish
pagine (da-a)132-138
Numero di pagine7
RivistaEuropean Journal of Pharmacology
Volume582
Stato di pubblicazionePublished - 2008

Fingerprint

Cannabinoid Receptor Antagonists
Cannabinoid Receptor CB1
Cannabinoid Receptor Agonists
rimonabant
Cannabinoids
Ileum
Muscles
Apamin
Endocannabinoids
Hexamethonium
NG-Nitroarginine Methyl Ester
Tetrodotoxin
Carbachol
Atropine
Nitric Oxide Synthase
Cholinergic Agents
Acetylcholine
Arginine

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cita questo

@article{e1b49506aafc4a1c959622048722f5c0,
title = "Cannabinoid CB1 receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.",
abstract = "The purpose of the present study was to examine whether cannabinoid receptor agonists influence spontaneous contractile activity oflongitudinal muscle in mouse ileum in vitro. Isolated segments of mouse ileum displayed spontaneous contractions with an amplitude andfrequency of about 300 mg and 30 cpm, respectively. The endocannabinoid anandamide (1–100 μM), the selective cannabinoid CB1 receptoragonist, ACEA (0.1 μM–10 μM), but not the selective cannabinoid CB2 receptor agonist, JWH 133 (0.1 μM–10 μM), reduced in a concentrationdependentmanner the spontaneous mechanical activity. The inhibitory effect consisted in a decrease of the mean amplitude of longitudinalspontaneous contractions, without changes in the resting tone. The inhibitory effect induced by cannabinoids was significantly antagonized by theselective cannabinoid CB1 receptor antagonist, SR141716A (0.1 μM), but not by the selective cannabinoid CB2 receptor antagonist, AM630(0.1 μM). None of the cannabinoid antagonists, at the concentration used, did affect the spontaneous mechanical activity. The ACEA-inducedreduction of spontaneous contractions was almost abolished by tetrodotoxin, atropine or apamin and it was unaffected by hexamethonium orNω-nitro-L-arginine methyl ester (L-NAME), inhibitor of nitric oxide synthase. The myogenic contractions evoked by carbachol were notaffected by ACEA. In conclusion, the present results suggest that activation of neural cannabinoid CB1 receptors may play a role in the controlof spontaneous mechanical activity through inhibition of acetylcholine release from cholinergic nerve. Activation of small conductance Ca2+-dependent K+ channels is involved in this action.",
author = "Flavia Mule' and Sara Baldassano and Serio, {Rosa Maria}",
year = "2008",
language = "English",
volume = "582",
pages = "132--138",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

TY - JOUR

T1 - Cannabinoid CB1 receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.

AU - Mule', Flavia

AU - Baldassano, Sara

AU - Serio, Rosa Maria

PY - 2008

Y1 - 2008

N2 - The purpose of the present study was to examine whether cannabinoid receptor agonists influence spontaneous contractile activity oflongitudinal muscle in mouse ileum in vitro. Isolated segments of mouse ileum displayed spontaneous contractions with an amplitude andfrequency of about 300 mg and 30 cpm, respectively. The endocannabinoid anandamide (1–100 μM), the selective cannabinoid CB1 receptoragonist, ACEA (0.1 μM–10 μM), but not the selective cannabinoid CB2 receptor agonist, JWH 133 (0.1 μM–10 μM), reduced in a concentrationdependentmanner the spontaneous mechanical activity. The inhibitory effect consisted in a decrease of the mean amplitude of longitudinalspontaneous contractions, without changes in the resting tone. The inhibitory effect induced by cannabinoids was significantly antagonized by theselective cannabinoid CB1 receptor antagonist, SR141716A (0.1 μM), but not by the selective cannabinoid CB2 receptor antagonist, AM630(0.1 μM). None of the cannabinoid antagonists, at the concentration used, did affect the spontaneous mechanical activity. The ACEA-inducedreduction of spontaneous contractions was almost abolished by tetrodotoxin, atropine or apamin and it was unaffected by hexamethonium orNω-nitro-L-arginine methyl ester (L-NAME), inhibitor of nitric oxide synthase. The myogenic contractions evoked by carbachol were notaffected by ACEA. In conclusion, the present results suggest that activation of neural cannabinoid CB1 receptors may play a role in the controlof spontaneous mechanical activity through inhibition of acetylcholine release from cholinergic nerve. Activation of small conductance Ca2+-dependent K+ channels is involved in this action.

AB - The purpose of the present study was to examine whether cannabinoid receptor agonists influence spontaneous contractile activity oflongitudinal muscle in mouse ileum in vitro. Isolated segments of mouse ileum displayed spontaneous contractions with an amplitude andfrequency of about 300 mg and 30 cpm, respectively. The endocannabinoid anandamide (1–100 μM), the selective cannabinoid CB1 receptoragonist, ACEA (0.1 μM–10 μM), but not the selective cannabinoid CB2 receptor agonist, JWH 133 (0.1 μM–10 μM), reduced in a concentrationdependentmanner the spontaneous mechanical activity. The inhibitory effect consisted in a decrease of the mean amplitude of longitudinalspontaneous contractions, without changes in the resting tone. The inhibitory effect induced by cannabinoids was significantly antagonized by theselective cannabinoid CB1 receptor antagonist, SR141716A (0.1 μM), but not by the selective cannabinoid CB2 receptor antagonist, AM630(0.1 μM). None of the cannabinoid antagonists, at the concentration used, did affect the spontaneous mechanical activity. The ACEA-inducedreduction of spontaneous contractions was almost abolished by tetrodotoxin, atropine or apamin and it was unaffected by hexamethonium orNω-nitro-L-arginine methyl ester (L-NAME), inhibitor of nitric oxide synthase. The myogenic contractions evoked by carbachol were notaffected by ACEA. In conclusion, the present results suggest that activation of neural cannabinoid CB1 receptors may play a role in the controlof spontaneous mechanical activity through inhibition of acetylcholine release from cholinergic nerve. Activation of small conductance Ca2+-dependent K+ channels is involved in this action.

UR - http://hdl.handle.net/10447/30065

M3 - Article

VL - 582

SP - 132

EP - 138

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -